Hyderabad-based biotechnology company BioVaram on Thursday said it has signed a MoU with Japan’s Teijin Limited to collaborate on expanding usage of Regenerative Medicine products and Implantable medical devices in Japan and India.
BioVaram, the University of Hyderabad incubated startup, is the brand name of the UR Advanced Therapeutics Pvt Ltd (URAT), a release said.
The collaboration aims to expand the reach of Teijin Group’s implantable medical devices and regenerative medicine products in India, while also introducing BioVaram’s advanced product portfolio to the Japanese market, it said.
“Under the terms of the agreement, Teijin and BioVaram will explore the regulatory approval and commercialisation of SYNFOLIUM?, a cardiovascular repair patch by Teijin Medical Technologies Co, Ltd, in India,” it said.
The collaboration will open up opportunities for expanding use of Japan Tissue Engineering Co, Ltd’s (part of the Teijin Group) regenerative medicine products in India.
The …
